References

1. Tibri ABM (1997) Zaheer (Paichish), Al-Moaljaat Buqratia, Central Council For Research in Unani Medicine 3: 406-407.
2. Azmi WA (1992) Zaheer, Moaljaat-Amraz-e- Hazam wa Toaleed wa Tanasil, Tariqi Urdu Bureau, India, 2: 299-305.
3. AL-Razi MBZ (2000) Amraz-e-Amaa, Kitab-ul-Hawi-Hawi Kabir, Central Council for Research in Unani Medicine, India 8: 16-21.
4. Batzing BL (2002) Microbial Growth, Microbiology- An Introduction, Wards Worth Group Brooks/cole, p 61, 64,69, 214 269, 270, 363, 476, 477.
5. Tortora JG, Funke BR, Case CL (2001) Shigellosis (Bacillary Dysentery), Microbiology An Introduction, Wesley Longman, 7th Edition, USA, p 691- 692. View
6. Keusch GT, Kopecko DJ (2005) Shigellosis, Harrison’s Principles of Internal Medicine-Infectious Diseases, 16th Edition, p 902-906.
7. Kumar P, Clark M (2005) Shigella, Clinical Medicine, Saunders, 6Th Edition, Philadelphia, p 69-72. View
8. Sansonetti PJ, Arondel J, Fontaine A, d'Hauteville H, Bernardini ML (1991) OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis. Vaccine 9: 416-422. View
9. Qureshi T, Saeed A, Usmanghani K, Asif HM (2014) Clinical Evaluation of Shigeldysent and Ciprofloxacin in the Treatment of Shigellosis. Eur J Biomed Pharma Sci 1: 77-85. View
10. Bye WA, Allan CH, Trier JS (1984) Structure, distribution, and origin of M cells in Peyer's patches of mouse ileum. Gastroenterology 86: 789-801. View
11. Neutra MR, Frey A, Kraehenbuhl JP (1996) Epithelial M cells: gateways for mucosal infection and immunization. Cell 86: 345-348. View
12. Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED (2008) Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol Infect 136: 577-603. View
13. WHO (2005) Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae. View
14. Taheri A, Seyfan A, Jalalinezhad S, Naser, Zahedan F (2013) Antibacterial Effect of Myrtus Communis Hydro-Alcoholic Extract on Pathogenic Bacteria. J Res Med Sci 15:19-24. View
15. Alem G, Mekonnen Y, Tiruneh M, Mulu A (2008) Invitro antibacterial activity of crude preparation of myrtle (Myrtus communis) on common human pathogens. Ethiop Med J 46: 63-69. View
16. Raja SB, Murali MR, Kumar NK, Devaraj SN (2011) Isolation and partial characterisation of a novel lectin from Aegle marmelos fruit and its effect on adherence and invasion of Shigellae to HT29 cells. PLoS One 6: e16231. View
17. Joshi PV, Patil RH, Maheshwari VL (2009) In vitro antidiarrhoeal activity and toxicity profile of Aegle marmelos Correa ex Roxb. dried fruit pulp. Nat Prod Radi 8: 498-502. View
18. Rani P, Vasisht K and Khullar N (2013) Bion-AutoFigurey: An efficient method to check the in vitro antimicrobial activity of Aegle marmelos against enteric pathogens. IIOAB-India IIOABJ 4: 4-9.
19. Rahman S, Parvin R (2014) Therapeutic potential of Aegle marmelos (L.)- An overview. Asian Pac J Trop Dis 4: 71-77. View
20. Liu P (2012) Composition of Hawthorn (Crataegus spp.), fruits and leaves of Emblica officinalis (Phyllanthus emblica) FRUITS, Department of Biochemistry and Food Chemistry and Functional Foods Forum University of TurkuTurku, Ph.D. thesis.
21. John S, Iyer P (2012) Antimicrobial Activity of Aloe vera barbedensis, Daucus carota, Emblica officinalis, Honey and Punica granatum and Formulation of a Health Drink and Salad Jeswin Philip. Malay J Microbiol 8: 141-147.
22. Dhiren N, Leo C, Sarav H, Ganesh M (2013) Efficacy of Citrus Fruit Peel Extracts Against Pathogens Causing Gastrointestinal Disorders. Ind J Novel Drug deli 5:103-107. View